- Zacks•12 days ago
AVEO Pharmaceuticals (AVEO) announced the submission of Day 120 List of Questions for tivozanib by EUSA Pharma.
- Business Wire•13 days agoAVEO Announces Submission of Responses to the EMA Day 120 List of Questions for Marketing Authorization Application for Tivozanib in Renal Cell Carcinoma
AVEO Oncology today announced that its development partner, EUSA Pharma, a specialty pharmaceutical company with a focus on oncology and oncology supportive care, has submitted its responses to the European Medicines Agency Day 120 List of Questions.
- Business Wire•19 days ago
AVEO Oncology today announced that Michael Bailey, president and chief executive officer, will present at the 28th Annual Piper Jaffray Healthcare Conference on Wednesday, November 30, 2016 at 3:30 PM Eastern Time.
AVEO : Summary for AVEO Pharmaceuticals, Inc. - Yahoo Finance
AVEO Pharmaceuticals, Inc. (AVEO)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||0.60 x 4300|
|Ask||0.63 x 700|
|Day's Range||0.60 - 0.65|
|52 Week Range||0.56 - 1.42|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-1.44|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|